This is a monoclonal antibody binds specifically to the cyclin-dependent kinase 5 (Cdk5) activating protein, p25 and not to p35, a hybridoma cell line producing the monoclonal antibody, and the use of the monoclonal antibody is for detection and treatment of neuronal disorders and cancers.